Submit Blog Post

D

Dr.Umesh Laddi's Med-Chemist

Do regularly update on FDA approvals, clinical trials, new
drugs, side effects, drug discovery, synthetic chemistry,
med, chemist,

  • Rated2.3/ 5
  • Updated 1 Year Ago

FDA Approves Krazati (adagrasib) for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation

Updated 1 Year Ago
By Dr.Umesh Laddi

FDA Approves Krazati (adagrasib) For Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC) With A KRASG12C Mutation
Read More